Treatments chosen for a woman’s body — and one care team that calibrates your GLP-1 dose to your labs, your goals, and your progress as one connected plan.
MostTirzepatide is a dual-receptor agonist that activates both GLP-1 and GIP pathways — the two pathways your body uses to regulate appetite and energy use. It is the first molecule of its kind to engage both receptors at once.
Semaglutide is a GLP-1 receptor agonist that targets the pathway your body uses to regulate appetite, satiety, and blood sugar response. It is the longest-tenured GLP-1 in clinical use, with the deepest body of research behind it.
Tirzepatide and semaglutide have observed up to a 25% reduction of body weight in patients. Done well — with nutrition guidance and quarterly panels — the loss is lasting.
Prescriptions are never automatic or guaranteed. Eligibility is evaluated case-by-case by a US-licensed clinician.
No surprise fees. No prepaid balance forfeiture. No 24-hour cancellation window. Medication is priced separately and disclosed before you confirm — never bundled into a hidden line item.
